Lymphaticovenous bypass (or LVB) is a surgical procedure designed to address lymphedema by restoring lymphatic drainage. The injured lymphatic channels are bypassed or connected to nearby tiny veins. This restores the natural flow of lymphatic fluid, allowing it to drain away. By creating this new pathway, LVB targets the root cause of lymphedema: the blockage of lymphatic drainage. The incisions required for this minimally invasive surgery are relatively small, typically about two finger-widths, as the lymphatic vessels and veins are located just beneath the skin's surface, avoiding deeper muscle or structural involvement.

Vascularized lymph node transfer (or VLNTx) is a surgical procedure that involves transplanting healthy lymph nodes from a donor site to the affected arm or leg. This technique aims to introduce working lymph nodes to the area where the lymphatic system is compromised. The transplanted nodes absorb excess lymphatic fluid and returning it to its normal circulation. VLNT is a more complex surgery than LVB, requiring incisions at both the donor area and the recipient site. It typically is a longer surgery with a longer recovery compared to LVB.

Minimally invasive tissue excision (or MITE), is also called suction-assisted protein lipectomy (or SAPL). It aims to reduce arm or leg size by removing excess scar tissue (fibrosis). Unlike LVB and VLNT, which improve lymphatic drainage, MITE directly addresses the accumulated fibrotic/scar tissue that causes limb enlargement. This procedure is performed to restore a more normal size when other treatments haven't achieved adequate volume reduction.